David Millar-Jones examines statements from the European Medicines Agency and MHRA regarding the use of ibuprofen in patients with COVID-19.
Create an account to add page annotations
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page